ArticleInternational journal of molecular sciences2026
Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in
Anton I Korbut, Elizaveta A Ananishnikova, Nikolai B Orlov, Nataliya P Bgatova, Natalia A Muraleva, Evgenii L Zavyalov, Vladimir I Konenkov, Vadim V Klimontov
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Anton I KorbutResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.ORCID 0000-0003-3502-5892 Elizaveta A AnanishnikovaResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.
Nikolai B OrlovResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.
Nataliya P BgatovaResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.ORCID 0000-0002-4507-093X Natalia A MuralevaInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (IC&G SB RAS); Novosibirsk 630090, Russia.ORCID 0000-0002-0665-1723 Evgenii L ZavyalovInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (IC&G SB RAS); Novosibirsk 630090, Russia.
Vladimir I KonenkovResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.
Vadim V KlimontovResearch Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.
Funding
Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
6 · The paper itselfAbstract
Accumulating data indicate a role for the dysregulation of the cell cycle, autophagy and apoptosis in diabetic kidney disease. We aimed to evaluate the mediators of the PI3K/Akt and MAPK/ERK signaling pathways in the kidney of
Indexed as
Benzhydryl CompoundsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2GlucosidesKidneyLinagliptinMAP Kinase Signaling SystemMetforminPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAnimalsDiabetic NephropathiesHypoglycemic AgentsMaleMiceSignal TransductionBenzhydryl CompoundsempagliflozinGlucosidesHypoglycemic AgentsLinagliptinMetforminPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktchronic kidney diseaseempagliflozinlinagliptinMAPK/ERK signalingmetforminPI3K/Akt signalingtype 2 diabetes
Identifiers
PMID42511826
PMCPMC13409939
What Socratic holds
Texttitle and abstract
LicenceCC BY
Read underepoch 390